01 1Taro Pharmaceutical Industries
01 1NAFTIFINE HYDROCHLORIDE USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-01
Pay. Date : 2013-07-25
DMF Number : 24619
Submission : 2012-06-27
Status : Active
Type : II
20
Taro Pharmaceutical Industries Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is NAFTIFINE HYDROCHLORIDE USP, with a corresponding US DMF Number 24619.
Remarkably, this DMF maintains an Active status since its submission on June 27, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 01, 2013, and payment made on July 25, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
